JLK said Thursday it will attend the International Stroke Conference (ISC 2025) at the Los Angeles Convention Center in the U.S. from Feb. 5 to 7.

ISC is an international scientific event co-organized by the American Heart Association and the American Stroke Association that brings together stroke experts worldwide to share the latest research findings.

JLC will introduce MEDIHUB STROKE, an artificial intelligence (AI) stroke analysis platform, and operate an interactive booth where visitors can play against AI. In the booth's center, a triangular pillar will allow medical professionals to compare the results of AI diagnosis with the results of a stroke patient's video analysis.

In a special session, the company will present the results of the study “Artificial Intelligence Improves Detection Sensitivity for Challenging Acute Ischemic Stroke Lesions on Diffusion-weighted Imaging.”

“As this is our first international event after receiving the Food and Drug Administration clearance, it will be an important milestone in our expansion into the U.S. market,” JLK CEO Kim Dong-min said. “We will do our best to introduce our solution to more medical institutions.”